StonvexLoading…
StonvexStonvexStonvexCore line items from KPTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $35.07M | $146.07M | $111.99M | $67.94M |
Operating Income | $-26.76M | $-90.71M | $-72.86M | $-57.64M |
Net Income | $-22.39M | $-196.04M | $-93.84M | $-60.71M |
EPS (Diluted) | $-1.24 | $-17.93 | $-10.93 | $-7.11 |
Total Assets | $131.42M | $108.42M | $96.23M | $104.88M |
Total Liabilities | $397.06M | $401.34M | $365.49M | $343.81M |
Cash & Equivalents | $90.85M | $60.54M | $37.67M | $38.73M |
Free Cash Flow OCF − CapEx | Not available | $-75.37M | $-63.54M | $-57.68M |
Shares Outstanding | 22.54M | 18.31M | 8.70M | 8.65M |